GnRH and LHR gene variants predict adverse outcome in premenopausal breast cancer patients
2007

Gene Variants Predict Breast Cancer Outcomes

Sample size: 278 publication 10 minutes Evidence: moderate

Author Information

Author(s): Piersma Djura, Themmen Axel PN, Look Maxime P, Klijn Jan GM, Foekens John A, Uitterlinden André G, Pols Huibert AP, Berns Els MJJ

Primary Institution: Erasmus MC

Hypothesis

The study investigates the prognostic significance of GnRH and LHR gene variants in premenopausal breast cancer patients.

Conclusion

The LHR insLQ and GnRH 16Ser alleles are independently associated with shorter disease-free survival in premenopausal breast cancer patients.

Supporting Evidence

  • Carriers of both the GnRH 16Ser and LHR insLQ alleles showed a significant increased risk of relapse.
  • The study included a long follow-up period of 11 years for living patients.
  • The findings suggest a potential for tailored treatment based on genetic testing.

Takeaway

Some women with specific gene variants have a higher chance of their breast cancer coming back after treatment.

Methodology

The study analyzed gene variants in 278 premenopausal breast cancer patients and compared them to 1,758 controls.

Potential Biases

Potential selection bias due to the retrospective nature of the study.

Limitations

The study is retrospective and may not account for all confounding factors.

Participant Demographics

Participants were premenopausal women with a median age of 45 years.

Statistical Information

P-Value

0.002

Confidence Interval

1.32 to 3.45

Statistical Significance

p=0.002

Digital Object Identifier (DOI)

10.1186/bcr1756

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication